Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells
- PMID: 22614258
- DOI: 10.3892/ijo.2012.1489
Casein kinase 2 inhibition modulates the DNA damage response but fails to radiosensitize malignant glioma cells
Abstract
Inhibitors of casein kinase 2 (CK2), a regulator of cell proliferation and mediator of the DNA damage response, are being evaluated in clinical trials for the treatment of cancers. Apigenin was capable of inhibiting the activation of CK2 following γ irradiation in LN18 and U87 malignant glioma cells. Apigenin and siRNA-mediated CK2 protein depletion further inhibited NF-κB activation and altered the Tyr68 phosphorylation of Chk2 kinase, a DNA damage response checkpoint kinase, following irradiation. However, CK2 inhibition did not decrease the ability of these glioma cells to repair double-strand DNA breaks, as assessed by COMET assays and γ-H2Ax staining. Likewise, apigenin and siRNA-induced depletion of CK2 failed to sensitize glioma cells to the cytotoxic effect of 2 to 10 G-rays of γ irradiation, as assessed by clonogenic assays. These results contrast with those found in other cancer types, and urge to prudence regarding the inclusion of malignant glioma patients in clinical trials that assess the radiosensitizing role of CK2 inhibitors in solid cancers.
Similar articles
-
Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.J Natl Cancer Inst. 2011 Apr 20;103(8):645-61. doi: 10.1093/jnci/djr093. Epub 2011 Apr 4. J Natl Cancer Inst. 2011. PMID: 21464397
-
Persistence of unrepaired DNA double strand breaks caused by inhibition of ATM does not lead to radio-sensitisation in the absence of NF-κB activation.DNA Repair (Amst). 2011 Feb 7;10(2):235-44. doi: 10.1016/j.dnarep.2010.11.005. Epub 2010 Dec 8. DNA Repair (Amst). 2011. PMID: 21144805
-
Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy.Int J Oncol. 2007 Oct;31(4):753-60. Int J Oncol. 2007. PMID: 17786305
-
[Casein kinase 2, the versatile regulator of cell survival].Mol Biol (Mosk). 2012 May-Jun;46(3):423-33. Mol Biol (Mosk). 2012. PMID: 22888632 Review. Russian.
-
Novel players in multiple myeloma pathogenesis: role of protein kinases CK2 and GSK3.Leuk Res. 2013 Feb;37(2):221-7. doi: 10.1016/j.leukres.2012.10.016. Epub 2012 Nov 19. Leuk Res. 2013. PMID: 23174190 Review.
Cited by
-
Minor Kinases with Major Roles in Cytokinesis Regulation.Cells. 2022 Nov 17;11(22):3639. doi: 10.3390/cells11223639. Cells. 2022. PMID: 36429067 Free PMC article. Review.
-
Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms.Pharmaceutics. 2022 Jan 30;14(2):331. doi: 10.3390/pharmaceutics14020331. Pharmaceutics. 2022. PMID: 35214064 Free PMC article. Review.
-
Apigenin directly interacts with and inhibits topoisomerase 1 to upregulate CD26/DPP4 on colorectal carcinoma cells.Front Pharmacol. 2022 Dec 22;13:1086894. doi: 10.3389/fphar.2022.1086894. eCollection 2022. Front Pharmacol. 2022. PMID: 36618939 Free PMC article.
-
DNA‑PKcs inhibitor increases the sensitivity of gastric cancer cells to radiotherapy.Oncol Rep. 2019 Aug;42(2):561-570. doi: 10.3892/or.2019.7187. Epub 2019 Jun 6. Oncol Rep. 2019. PMID: 31173270 Free PMC article.
-
Association of protein kinase CK2 inhibition with cellular radiosensitivity of non-small cell lung cancer.Sci Rep. 2017 Nov 23;7(1):16134. doi: 10.1038/s41598-017-16012-1. Sci Rep. 2017. PMID: 29170453 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
